BioSpace News Archive

eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of safe and effective human-compatible organs to address the global organ shortage, today announced the successful completion of a $100 million Series B financing.

INmune Bio, Inc., an immunology company developing treatments that harness the patient’s innate immune system to fight disease, reported its financial results for the third quarter ended September 30, 2019 and is providing a business update.

Akoya Biosciences, Inc., The Spatial Biology Company™, announced that it has launched two new multiplex immunofluorescence kits, expanding its portfolio of solutions for profiling immuno-oncology biomarkers in the tumor microenvironment.

Ningbo Tai Kang Medical Technology Co. Ltd. announced today that it has entered into a licensing agreement with AstraZeneca. Tai Kang has been granted the exclusive global rights to further develop and commercialize AZD3229, a small molecule KIT inhibitor that is active against primary, secondary and resistant KIT and PDGFRα mutations observed in gastrointestinal stromal tumor (GIST).

HealthGrowth Capital, LLC, a leading lender and strategic consultant to independent pharmacies, is pleased to announce the appointment of Todd C. Ebert to the Company’s Board of Advisors, effective immediately.

Four innovative technologies from Dow, the world’s leading materials science company, were recognized with 2019 R&D 100 awards from R&D World magazine and its new parent company, WTWH Media, LLC.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has commenced tender offers (the “Offers”) to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest but inclusive of tender premium) of up to $1,500,000,000 (the “Maximum Amount”) of the following series of notes issued by finance subsidiaries of Teva and guaranteed by Teva

Colorado BioScience Association celebrated the companies and organizations developing life-saving breakthroughs at its Annual Awards Dinner, held on November 7 at the Hyatt Regency in Denver.

The Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation (Elvin Howard, Sr. PCAF) will premiere a new public service announcement (PSA) to raise awareness of pancreatic cancer in people of color on Friday, November 8, at its annual benefit.

In the United States, lung cancer claims more women’s lives each year than breast, ovarian, and cervical cancers combined. In many countries around the world, it has become the leading cause of cancer death in women